Cancer cells treated with Doxorubicin stimulate the secretion of EVs enriched in the protein ATP-binding cassette sub-family B member 1 (ABCB1), a transporter involved in promoting the efflux of chemotherapeutic drugs (59), by the upregulation of Rab8B and downregulation of Rab5 proteins. Here, RAB5A is linked to cancer.